142 related articles for article (PubMed ID: 6977542)
21. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
Schrader WP; Pollara B; Meuwissen HJ
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
[TBL] [Abstract][Full Text] [Related]
22. Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.
Herbschleb-Voogt E; Scholten JW; Meera Khan P
Hum Genet; 1983; 63(2):121-5. PubMed ID: 6840756
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Chan TS; Huang C; Sato T
Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
[TBL] [Abstract][Full Text] [Related]
24. Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.
Adrian GS; Wiginton DA; Hutton JJ
Hum Genet; 1984; 68(2):169-72. PubMed ID: 6548726
[TBL] [Abstract][Full Text] [Related]
25. Purine metabolism in adenosine deaminase deficiency.
Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
[TBL] [Abstract][Full Text] [Related]
26. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
Hirschhorn R; Ellenbogen A
Am J Hum Genet; 1986 Jan; 38(1):13-25. PubMed ID: 3946419
[TBL] [Abstract][Full Text] [Related]
27. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
Carson DA; Wasson DB; Lakow E; Kamatani N
Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
29. Hot spot mutations in adenosine deaminase deficiency.
Hirschhorn R; Tzall S; Ellenbogen A
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6171-5. PubMed ID: 2166947
[TBL] [Abstract][Full Text] [Related]
30. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC
J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861
[TBL] [Abstract][Full Text] [Related]
32. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
Carson DA; Wasson DB; Lakow E; Kamatani N
Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
[No Abstract] [Full Text] [Related]
33. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
Rubinstein A; Hirschhorn R; Sicklick M; Murphy RA
N Engl J Med; 1979 Feb; 300(8):387-92. PubMed ID: 310515
[TBL] [Abstract][Full Text] [Related]
34. Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.
Herbschleb-Voogt E; Pearson PL; Vossen JM; Meera Khan P
Hum Genet; 1981; 56(3):379-86. PubMed ID: 7239521
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
36. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease.
Carson DA; Goldblum R; Seegmiller JE
J Immunol; 1977 Jan; 118(1):270-3. PubMed ID: 830750
[TBL] [Abstract][Full Text] [Related]
37. Increased purine nucleotides in adenosine deaminase-deficient lymphocytes.
Schmalstieg FC; Nelson JA; Mills GC; Monahan TM; Goldman AS; Goldblum RM
J Pediatr; 1977 Jul; 91(1):48-51. PubMed ID: 195028
[TBL] [Abstract][Full Text] [Related]
38. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
Raivio KO; Schwartz AL; Stern RC; Polmar SH
Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
[No Abstract] [Full Text] [Related]
39. Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency.
Schwartz AL; Stern RC; Polmar SH
Clin Immunol Immunopathol; 1978 Apr; 9(4):499-505. PubMed ID: 206401
[No Abstract] [Full Text] [Related]
40. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
Chan TS
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
